ARS PHARMACEUTICALS, INC. (SPRY)
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ARS Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - SPRY
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ARS Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - SPRY
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines - REPL
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Alarum Technologies Ltd. of Class Action Lawsuit and Upcoming Deadlines - ALAR
BitGo Acquires NYDIG’s Institutional Trading Business, Expanding Derivatives and Financing Capabilities
Riassunto: Perma-Pipe annuncia la chiusura della linea di credito globale di un massimo di 139 milioni di dollari
Koss Corporation Releases Fourth Quarter and Full Year Results
Kioxia e SanDisk investirão mais de US$ 31 bilhões no Japão, ampliando a liderança no setor de memórias